| Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108) |
|---|
| 04/29/2004 | WO2004035561A1 3-(cyclopenten-1-yl)-benzyl- or 3-(cyclopenten-1-yl)-heteroarylmethyl-amine derivatives and use thereof as medicines for treating schizophrenia |
| 04/29/2004 | WO2004035556A1 Substituted piperazines, (1,4) diaszepines, and 2,5-diazabicyclo (2.2.1) heptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists |
| 04/29/2004 | WO2004035522A1 Diagnostic probes and remedies for diseases with accumulation of prion protein, and stains for prion protein |
| 04/29/2004 | WO2004035521A1 Bis-alkylbenzylamines |
| 04/29/2004 | WO2004016221A3 Sulfonamides as potassium channel blockers |
| 04/29/2004 | WO2004013079A8 Ketocampholenic acid derivatives and their use in fragrance and flavour applications |
| 04/29/2004 | WO2003097649A3 1-oxa-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof |
| 04/29/2004 | WO2003093242A3 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade |
| 04/29/2004 | WO2003009807A3 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
| 04/29/2004 | WO2002078626A3 Therapeutic combinations for cardiovascular and inflammatory indications |
| 04/29/2004 | US20040082820 Hydrogen transfer reduction; useful as intermediate for production of pharmaceuticals/agricultural chemicals |
| 04/29/2004 | US20040082780 Vanilloid receptor ligands and their use in treatments |
| 04/29/2004 | US20040082671 Process for catalytic selective oxidation of a hydrocarbon substrate |
| 04/29/2004 | US20040082663 Imidazoline receptor binding compounds |
| 04/29/2004 | US20040082625 Osteoporosis, bone disorders |
| 04/29/2004 | US20040082585 Anticoagulants; controlling thrombosis; cardiovascular disorders |
| 04/29/2004 | US20040082576 Cardiovascular disorders; anticancer agents; antidiabetic agents; dietetics |
| 04/29/2004 | US20040082562 Novel inhibitors of IMPDH enzyme |
| 04/29/2004 | US20040082550 Tropolone derivative |
| 04/29/2004 | CA2502249A1 Substituted piperazines, (1,4) diaszepines, and 2,5-diazabicyclo (2.2.1) heptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists |
| 04/29/2004 | CA2501979A1 Large conductance calcium-activated k channel opener |
| 04/29/2004 | CA2496633A1 Diagnostic probes and remedies for diseases with accumulation of prion protein, and stains for prion protein |
| 04/28/2004 | EP1413580A1 Furanone derivatives as inhibitors of Cathepsin S |
| 04/28/2004 | EP1413569A1 Bicyclic cyclopropane derivatives capable of polymerisation and their use in the preparation of dental materials |
| 04/28/2004 | EP1412349A2 Piperazine oxyquinoline (naphthaline) platelet adenosine diphosphate receptor antagonists |
| 04/28/2004 | EP1412342A1 Process for the production of beraprost and its salts |
| 04/28/2004 | EP1412341A1 Process for the preparation of racemic citalopram and/or s- or r-citalopram by separation of a mixture of r- and s-citalopram |
| 04/28/2004 | EP1412340A2 Process for the preparation of citalopram hydrobromide |
| 04/28/2004 | EP1412335A2 ENANTIOSELECTIVE TRANSFORMATION OF $g(a), $g(b)-UNSATURATED ALDEHYDES USING CHIRAL ORGANIC CATALYSTS |
| 04/28/2004 | EP1412326A1 Butyric acid derivatives |
| 04/28/2004 | EP1412325A1 Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes |
| 04/28/2004 | EP1412077A1 Flow reactors for chemical conversions with hetergeneouos catalysts |
| 04/28/2004 | EP1411929A2 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 04/28/2004 | EP1411919A1 (-)-olivil as antioxidant |
| 04/28/2004 | EP1313724B1 N-heteroarylmethyl-p-phenylendiamine derivatives and compounds containing oxidation colouring agents |
| 04/28/2004 | EP1294682B1 Acylphenyl urea derivatives, methods for the production thereof and use thereof as a medicament |
| 04/28/2004 | EP1263714B1 Novel phenylheteroalkylamine derivatives |
| 04/28/2004 | EP1200384B1 2-alkyl-5-halogen-pent-4-ene carboxylic acids and their production |
| 04/28/2004 | EP1154983B1 Novel substituted 3-phenoxy and 3-phenylalkyloxy-2-phenyl-propylamines |
| 04/28/2004 | EP1137631B1 REVERSIBLE AQUEOUS pH SENSITIVE LIPIDIZING REAGENTS, COMPOSITIONS AND METHODS OF USE |
| 04/28/2004 | EP1042313B1 Benzopyran and benzothiopyran derivatives having retinoid antagonist like activity |
| 04/28/2004 | EP0777662B1 Ring d-modified gibberellin compounds, and preparation and use thereof |
| 04/28/2004 | EP0403618B2 Methyl esters of aldimino- or ketimino-oxy-ortho-tolylacrylic acid, manufacturing process and fungicides containing them |
| 04/28/2004 | CN1492861A Process for preparation of citalopram |
| 04/28/2004 | CN1492852A N-phenpropylcyclopentyl-substituted glutaramide derivatives as NEP inhibitors for FSAD |
| 04/28/2004 | CN1491948A Spliting method for DL-pantoyl internal ester |
| 04/28/2004 | CN1147492C New metal protease inhibitors its preparing method and their medicinal composition containing them |
| 04/28/2004 | CN1147461C 3-amino-3-aryl-1-alcohol derivatives and preparation and use thereof |
| 04/28/2004 | CN1147459C Galcium receptor-active compound |
| 04/28/2004 | CN1147358C Hollow cylindrical catalyst and method for producing maleic acid anhydride |
| 04/27/2004 | US6727370 Reacting halophthalic anhydride with alkali metal carbonate in presence of phase transfer catalyst; etherification, dehalogenation, coupling |
| 04/27/2004 | US6727279 Central nervous system disorders |
| 04/27/2004 | US6727250 Administering compounds such as trans-3-(naphth-2-yl)-but-2-enoic acid-n-(2-carboxy-phenyl)-amide or like for therapy of conditions associated with increased telomerase activity, e.g. tumour diseases |
| 04/27/2004 | US6727098 Circular dichroism |
| 04/22/2004 | WO2004033391A1 Method for catalytic oxygenation of cyclic ethers with homo and hetero metallic mo/ru complexes and molecular oxygen |
| 04/22/2004 | WO2004032871A2 Piperazine and piperazinone inhibitors of factor xa |
| 04/22/2004 | WO2004032845A2 R-nsaid esters and their use |
| 04/22/2004 | WO2003082263A8 Sulfamic acids as inhibitors of human cytoplasmic protein tyrosine phosphatases |
| 04/22/2004 | WO2003041728A9 Novel phenyl-propargylether derivatives |
| 04/22/2004 | WO2002094794A8 4 (phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain anxiety or gastrointestinal disorders |
| 04/22/2004 | WO2000061134A9 Antimicrobial agents |
| 04/22/2004 | US20040077883 Suspending plant material or extract in the presence of an oxidizer, extracting terpene trilactones and separating |
| 04/22/2004 | US20040077882 Polymerizable bicyclic cyclopropane derivatives and their use for the preparation of dental materials |
| 04/22/2004 | US20040077870 The phthalide is reacted with a Lewis acid to form an adduct, prior to reaction with the Grignard reagent; reducing by-product formation and improving yields; purified citalopram hydrobromide |
| 04/22/2004 | US20040077868 Process |
| 04/22/2004 | US20040077867 Amine compounds, their production and use |
| 04/22/2004 | US20040077861 Asymmetric addition of organometallic compounds to chiral sulfinimine to give adducts in predominantly one diastereomer can subsequently be transferred into pure enantiomers of by cleavage of the chiral auxilliary |
| 04/22/2004 | US20040077726 Antiproliferative and anticarcinogenic agents; psoriasis |
| 04/22/2004 | US20040077712 Resolution with acid; salt formation, cyclization |
| 04/22/2004 | US20040077620 Hypoglycemic agent |
| 04/22/2004 | US20040077553 Such as 1-(((alpha-propanoyloxybutoxy)carbonyl)aminomethyl)-1-cyclohexane acetic acid; ability to cross blood brain barrier; sustained release |
| 04/22/2004 | US20040077098 An optical resolving reagent comprising a bicyclo(3.3.0)-1-oxaoctane compound or a bicyclo(3.3.0)-1-oxa-6-octene compound |
| 04/22/2004 | CA2501239A1 R-nsaid esters and their use |
| 04/21/2004 | EP1411052A1 Benzo-fused 5-membered hetrocycle compounds,process for preparation of the same, and use thereof |
| 04/21/2004 | EP1409472A1 Method for the preparation of escitalopram |
| 04/21/2004 | EP1409468A2 Guanidinobenzamides as mc4-r agonists |
| 04/21/2004 | EP1409466A2 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
| 04/21/2004 | EP1409456A2 Detection of transmembrane potentials by optical methods |
| 04/21/2004 | EP1409450A1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
| 04/21/2004 | EP1409441A1 Indane compounds with negative dielectric anisotropy |
| 04/21/2004 | EP1409440A1 A method to inhibit ethylene responses in plants |
| 04/21/2004 | EP1408959A1 Use of galiella lactone |
| 04/21/2004 | EP1408958A1 Benzofuranes and their use in the treatment of atrial fibrillation |
| 04/21/2004 | EP1408946A2 Histone deacetylase inhibitors |
| 04/21/2004 | EP1149094B1 4-(aminoalkoxy)benzofurans as n-myristoyltransferase inhibitors |
| 04/21/2004 | EP1105370B1 Novel aryl sulphonamides and analogues |
| 04/21/2004 | EP0904262B1 Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method |
| 04/21/2004 | CN1491220A Lactone compound as novel photoinitiators |
| 04/21/2004 | CN1491219A Process for producing ascorbic acid in presence of sulfit |
| 04/21/2004 | CN1491207A Acylated indanyl amines and their use as pharmaceuticals |
| 04/21/2004 | CN1491197A Tropolone derivative |
| 04/21/2004 | CN1146683C Optical brightening agent |
| 04/21/2004 | CN1146553C Hydroxymatatairesinol in cancer prevention |
| 04/21/2004 | CN1146542C Benzamide derivatives and their use as cytokine inhibitors |
| 04/21/2004 | CN1146540C Novel compound with analgesic effect and use thereof |
| 04/21/2004 | CN1146536C Cycloethylene derivatives |
| 04/20/2004 | US6723847 3-oxo-n-(5-phenyl-2-pyrimidinyl)spiro(4-azaisobenzofuran-1 (3h),1'-cyclohexane)-4'-carboxamide; neuropeptide y receptor antagonists |
| 04/20/2004 | US6723753 Substituted n-benzyl-n-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
| 04/20/2004 | US6723752 (R)-chiral halogenated substituted n-benzyl-n-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
| 04/20/2004 | US6723718 Substituted α, β-anellated butyrolactones |